'%3e%3cpath%20d='M34.1406%205.85938C30.3906%202.10547%2025.3047%200%2020%200C14.6953%200%209.60938%202.10547%205.85938%205.85938C2.10938%209.61328%200%2014.6953%200%2020C0%2025.3047%202.10547%2030.3906%205.85938%2034.1406C9.61328%2037.8906%2014.6953%2040%2020%2040C25.3047%2040%2030.3906%2037.8945%2034.1406%2034.1406C37.8906%2030.3906%2040%2025.3047%2040%2020C40%2014.6953%2037.8945%209.60938%2034.1406%205.85938ZM37.0117%2023.543H31.1602V13.5391H27.6328V19.9414C28.1211%2020.6914%2028.3711%2021.582%2028.3711%2022.5625V22.625C28.3711%2023.668%2028.1172%2024.6055%2027.6328%2025.4297V26.6094H36.082C33.4883%2032.9375%2027.2891%2037.3789%2020.0039%2037.3789C10.3711%2037.3789%202.62109%2029.6289%202.62109%2020C2.62109%2010.3711%2010.3711%202.62109%2020%202.62109C29.6289%202.62109%2037.3789%2010.3711%2037.3789%2020C37.3789%2021.1484%2037.2617%2022.2656%2037.0508%2023.3477C37.0391%2023.4141%2037.0234%2023.4766%2037.0117%2023.543Z'%20fill='white'/%3e%3cpath%20d='M22.3086%2018.5352C20.4336%2018.125%2019.9531%2017.8398%2019.9766%2017.1836V17.1406C19.9766%2016.6992%2020.3477%2016.2148%2021.4023%2016.2148C22.582%2016.2148%2023.8867%2016.6797%2025.0781%2017.4766L26.8516%2015.0195C25.4453%2013.8906%2023.707%2013.3398%2021.5547%2013.3398C18.5195%2013.3398%2016.4375%2015%2016.4063%2017.4766V17.5352C16.3633%2020.2617%2018.5859%2020.9805%2021.293%2021.6016C23.0391%2021.9766%2023.5703%2022.3164%2023.5703%2022.9609L23.5469%2022.9766C23.5469%2023.3906%2023.2578%2023.7031%2022.7852%2023.8359C22.5742%2023.9062%2022.1289%2023.9727%2021.5156%2023.9727C20.7617%2023.9727%2019.7539%2023.8633%2018.6328%2023.4844C18.0898%2023.2891%2017.4727%2023.0039%2016.8047%2022.6133L20.1406%2026.625C20.2813%2026.6602%2021.0977%2026.8516%2021.7734%2026.8516C25.0039%2026.8516%2027.0859%2025.2461%2027.1094%2022.6328V22.5703C27.1602%2020.1133%2025.2148%2019.1719%2022.3086%2018.5352Z'%20fill='white'/%3e%3cpath%20d='M5.24219%2013.5664V26.6133H8.75391V23.7578L10.2969%2021.9531L14.2031%2026.6133H18.3867L12.3555%2019.5195L17.4023%2013.5664H13.4531L8.75391%2019.0586V13.5664H5.24219Z'%20fill='white'/%3e%3c/g%3e%3cdefs%3e%3cclipPath%20id='clip0_97_2430'%3e%3crect%20width='40'%20height='40'%20fill='white'/%3e%3c/clipPath%3e%3c/defs%3e%3c/svg%3e)
Lifestyle Features
Most Recent
Cutting these types of foods may ease depression symptoms
Lois M. Collins, Deseret News | Posted Sept. 27 - 7:04 p.m. | Save Story
Add this to the list of ills that might be linked to eating ultra-processed foods: A small UC San Francisco pilot study suggests that cutting back on ultra-processed foods may help improve depression symptoms, although larger trials are needed to confirm the findings.
How a bad prom haircut launched an Atlanta barber's lifelong career
Jamal Goss, WUPA | Posted Sept. 27 - 12:03 p.m. | Save Story
Master barber Ali Da Barber says it all started when his barber made a mistake before his prom, and he went home determined to fix it himself.
Merck, Daiichi pull US application for second partnered cancer therapy
Reuters | Updated Sept. 25 - 3:29 p.m. | Save Story
Merck and Daiichi Sankyo have withdrawn their US application seeking accelerated approval for an experimental lung cancer therapy, the companies said on Friday, marking the second pullback under their multibillion-dollar cancer alliance.
WHO says Congo Ebola outbreak spreads to two new health zones
Siddhi Mahatole, Reuters | Updated Sept. 25 - 1:13 p.m. | Save Story
The World Health Organization said on Friday that the Ebola outbreak caused by the Bundibugyo virus in the Democratic Republic of the Congo has spread to two additional health zones, bringing the total number affected to 63 across seven provinces.
ADARx Pharmaceuticals shares soar in Nasdaq debut after upsized IPO
Pragyan Kalita, Reuters | Updated Sept. 25 - 11:26 a.m. | Save Story
Shares of ADARx Pharmaceuticals rose 30% above their initial public offering price on Friday after the late-stage gene therapy developer raised $446.3 million in an upsized US initial public offering.
The harvest moon pairs up with Saturn for a 2-for-1 celestial display
Ashley Strickland, CNN | Updated Sept. 25 - 8:46 a.m. | Save Story
Get ready for a celestial double treat. The first full moon of the fall season will reach peak illumination in the night sky this weekend, and sky-gazers will also have a chance to spot Saturn.
Nanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology
Reuters | Updated Sept. 25 - 8:14 a.m. | Save Story
Shares in Swedish drug-delivery company Nanexa more than doubled their value in early Friday trading after it signed a global licensing deal with Novo Nordisk worth up to about €1.17 billion ($1.33 billion).
City Therapeutics files for US IPO as biotech listings surge
Reuters | Updated Sept. 24 - 4:25 p.m. | Save Story
City Therapeutics filed for a US initial public offering on Thursday, joining a rush of biotech firms lining up to tap the fall IPO window.
Las Vegas officials want more people to visit. Here's how they're doing it
KSL | Posted Sept. 24 - 1:33 p.m. | Save Story
Las Vegas officials are bringing back a citywide promotion featuring more than 180 limited-time travel discounts across the Las Vegas strip, downtown, and surrounding resorts.
MercadoLibre launches deliveries within an hour, expands pharmacy business in Brazil
Reuters | Updated Sept. 24 - 1:26 p.m. | Save Story
MercadoLibre launched product deliveries within an hour in Brazil, starting in the city of Sao Paulo, Fernando Yunes, the firm's executive vice president of commerce, said on Thursday.
USPS releases mailing deadlines for holiday shoppers
| Posted Sept. 24 - 12:50 p.m. | Save Story
The United States Postal Service wants to help customers mail their holiday packages in a timely manner, so it announced a few deadlines.
Anthropic, OpenEvidence partner to bring medical AI worldwide
Nancy Lapid, Reuters | Updated Sept. 24 - 10:40 a.m. | Save Story
(Corrects para 2 to indicate the platform is free to clinicians in the US and Canada)
Roche, Atavistik Bio sign drug-discovery deal worth up to $2 billion
Kunal Das, Reuters | Updated Sept. 24 - 8:55 a.m. | Save Story
Atavistik Bio said on Thursday it has signed a deal with Swiss drugmaker Roche potentially worth nearly $2 billion, including milestone payments, to develop oral treatments for cardiovascular, kidney and metabolic diseases.
China's InnoCare, Eli Lilly sign collaboration deal worth up to $3.35 billion
Reuters | Updated Sept. 24 - 8:53 a.m. | Save Story
Chinese drugmaker InnoCare Pharma said on Thursday it had entered into a research collaboration and licensing agreement with Eli Lilly worth up to about $3.35 billion.
Merck's drug for diabetes-related eye disease meets trial goal
Christy Santhosh, Reuters | Updated Sept. 24 - 8:52 a.m. | Save Story
Merck said on Thursday its injectable drug for a serious eye disease affecting people with diabetes was as effective as the current standard treatment in improving visual sharpness in a clinical trial.
Acadia's Alzheimer's psychosis drug misses main goal of mid-stage study
Sahil Pandey, Reuters | Updated Sept. 24 - 8:39 a.m. | Save Story
Acadia Pharmaceuticals said on Thursday its experimental drug for psychosis associated with Alzheimer's disease missed the main goal of a mid-stage study, sending the drugmaker's shares down about 11%.
Utah group to hold vigil honoring state's 2026 murder victims
KSL | Posted Sept. 23 - 5:44 p.m. | Save Story
Friday is a National Day of Remembrance for Homicide Victims, to honor those killed in Utah and to support the families and loved ones of the victims.
Anthropic says Claude AI helped discover novel enzyme system
Reuters | Updated Sept. 23 - 3:12 p.m. | Save Story
Anthropic on Wednesday said its Claude model helped discover a novel enzyme system with properties reminiscent of mechanisms in gene-editing technology CRISPR, marking the first result from the AI startup's biology research efforts.
